Kantar Health acquires Brazilian healthcare consulting firm Evidencias
Kantar Health has acquired Evidências, an industry leader in evidence-based, health management services in Brazil. Known for its strong scientific reputation, Evidências works with all segments of the Brazilian healthcare market, including health insurers, government bodies, hospitals and providers, and pharmaceutical and medical device manufacturers.
The acquisition expands Kantar Health’s presence in an important emerging market and provides the company with new capabilities in cost effectiveness and budget impact economic models, local dossier submission packages and professional writing.Kantar Health also receives valuable expertise in the DATASUS governmental database and a key private insurance database covering 20 percent of the privately insured population in Brazil – offering a complete picture of the healthcare sector in the country. Evidências gains access to Kantar Health’s leading data assets and global team of healthcare consultants, allowing Evidências to strengthen its work in evidence-based medicine and further extend its range of services in consulting, market access and training.
“This partnership brings together two highly talented and scientific teams and further strengthens Kantar Health’s presence in this important emerging healthcare market,” said Mike Kelly, CEO Americas, Kantar Health. “Combined, Kantar Health and Evidências will give clients unparalleled access to new sources of healthcare information and enhanced scientific expertise, health economics modeling, clinical studies and market access.”
Through this acquisition, Kantar Health will be able to provide better coordination of market access and health outcomes in Brazil, while allowing both companies to expand their current client bases and deliver local support for Kantar Health’s National Health and Wellness Survey, CancerMPact®, Forecast Architect® and Epi Database® offers.
“Evidências has established itself as one of the premier health management companies in Brazil through our focused approach to evidence-based medicine and enhanced decision making for health technologies and market analysis,” said Otávio Clark, president and projects development team leader for Evidências. “We are excited to become part of Kantar Health and look forward to continuing to deliver unprecedented scientific, health outcomes and market access expertise to clients in Brazil.”